BioSpace News Archive

The development in biomarker technologies market is because of ascend in R&D exercises and flood in predominance of illnesses like different sorts of malignant growth, diabetes type 1, AIDS, rheumatoid joint pain, and others.

Increase in awareness of fertility testing, launch of technologically advanced products with high accuracy, and declining fertility rates across the globe drive the global fertility test market.

- Voting is open to the public now through September 1 to help determine this year’s two Thriving Scholars - Forty students living with cystic fibrosis who have demonstrated academic excellence, creativity, and community involvement/extracurricular activities are in the running

The American Board of Medical Specialties (ABMS) has named Amy Gibson , MS, RN its Vice President, Policy and Public Affairs.

Rise in number of surgical procedures, surge in patient preference for minimally invasive surgeries, and surge in regulatory approvals have boosted the growth of the global hybrid operating room market.

BioCheck, Inc. has announced that it has acquired DRG International, a leading manufacturer of clinical diagnostic and research ELISAs with distributors in over 110 countries.

Scioto Biosciences, Inc. announced the beginning of their Phase Ib clinical trial for their lead investigational product SB-121 for the treatment of Autistic Disorder (AD).

Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact, is pleased to highlight positive results from an independent analysis of standard surgical risk patients undergoing carotid endarterectomy and transcarotid artery revascularization for atherosclerotic carotid disease.

Omnicell, Inc. today announced its latest enhancements to the Company’s industry-leading portfolio of medication management solutions.

Conformis, Inc. (NASDAQ:CFMS) today announced the first procedure with the new Conformis Identity Imprint knee replacement system.